This clinical trial focuses on understanding how antibiotics work in women who are pregnant with twins. The study involves several antibiotics, including piperacillin, tazobactam, cefazolin, ampicillin sodium, and clindamycin. These medications are commonly used to treat infections and will be given through a vein, known as intravenous use. The purpose of the study is to determine the concentration of these antibiotics in the blood of the mother and the newborns, specifically looking at any differences between the twin siblings.
Participants in the study will be women with twin pregnancies who are having a cesarean section, which is a surgical procedure to deliver the babies. The study will measure the levels of antibiotics in the mother’s blood and the blood from the umbilical cord, which connects the mother to the babies. This will help researchers understand how the antibiotics are distributed in the body and how they might affect the twins differently. The study will also look at the safety and any side effects of the antibiotics used.
The trial aims to provide valuable information about the use of antibiotics during twin pregnancies, which can help improve treatment and care for both mothers and their babies. By studying the differences in antibiotic levels between the twins, researchers hope to gain insights into how these medications work in such unique pregnancies. The study is expected to continue until 2025, gathering data to ensure the safety and effectiveness of these treatments.



Austria